BioCentury | Oct 20, 2020
Management Tracks

J&J promotes Kumar; plus moves at Krystal, Design, Centogene, Lyndra, Mereo and Neoleukin

...was associate general counsel at the non-profit.Could an IPO soon be in the works for Lyndra...
...companies public. The addition of  Eldridge is the third senior management hire this year for Lyndra...
...at Kartos Therapeutics Inc. Wyzga will continue to serve on Mereo’s board. Danielle Golovin Krystal Biotech Inc. Design Therapeutics Centogene N.V. Lyndra...
BioCentury | Dec 6, 2019
Preclinical News

Dec. 5 Preclinical Quick Takes: Simpler synthesis of Merck’s HIV therapy; plus MRSA antibiotic, once-monthly oral contraceptive

...infected moth larvae. MIT’s once-monthly oral contraceptive A Massachusetts Institute of Technology team led by Lyndra...
...contraceptive was detected in serum up to 29 days after oral delivery of the capsule. Lyndra...
...infectious and neurological diseases, transplant rejection and contraception (see “Star Treatment” ). BioCentury Staff Massachusetts Institute of Technology Lyndra...
BioCentury | Oct 4, 2019
Company News

Management tracks: J&J hires Bayer’s Swanson; plus Torque, Dynavax, Pact, Deciphera, NextCure, Retrophin, Verve, Jnana and more

...CSO. Bellinger is an attending cardiologist at Brigham and Women's Hospital and was CSO at Lyndra...
BioCentury | Jul 9, 2019
Company News

July 9 Company Quick Takes: Celgene, Nimbus expand deal; plus Gilead-Lyndra, Darzalex and more

...Gilead, Lyndra to develop long-acting HIV therapies Gilead Sciences Inc. (NASDAQ:GILD) gained exclusive rights from Lyndra...
...Financial terms are undisclosed. Gilead participated in Lyndra's $60.9 million series B in January (see "Lyndra...
...Eaton, Staff Writer Darzalex, daratumumab (JNJ-54767414, humax-cd38) SP-1373, VPD-107 tislelizumab (BGB-A317) Alector Inc. Altimmune Inc. BeiGene Ltd. Celgene Corp. Gilead Sciences Inc. Johnson & Johnson Lyndra...
BioCentury | Jun 3, 2019
Company News

Management tracks: Zai, Jazz, PTC, BIO and more

...biopharma division of the GE Healthcare unit of General Electric Co. (NYSE:GE). Drug delivery company Lyndra...
...preclinical sciences at Vertex Pharmaceuticals Inc. (NASDAQ:VRTX). Mark Zipkin, Staff Writer Biotechnology Industry Organization Jazz Pharmaceuticals plc Leo Pharma A/S Lyndra...
BioCentury | Mar 13, 2019
Preclinical News

Langer study describes once-monthly dosing system for tuberculosis

...The scientific team behind drug delivery company Lyndra Therapeutics described a delivery device capable of releasing...
...treatment regimens last 6-9 months, according to the CDC. Langer and Traverso are co-founders of Lyndra...
...is developing oral drug delivery systems for ultra-long drug release. All of the candidates in Lyndra's...
BioCentury | Feb 1, 2019
Financial News

Drug delivery company Lyndra raises $55M series B

...Investments, Gilead Sciences Inc. (NASDAQ:GILD), Invus, the Bill & Melinda Gates Foundation and Orient Life. Lyndra...
...Lyndra is testing capsule formulations of generic drugs and proprietary compounds from partner companies. Lyndra...
...2019 and progress to a Phase II trial in 2020. Lyndra Therapeutics Inc., Watertown, Mass. Hongjiang Li Lyndra...
BioCentury | Jan 29, 2019
Financial News

Drug delivery company Lyndra raises $55M series B

...Investments, Gilead Sciences Inc. (NASDAQ:GILD), Invus, the Bill & Melinda Gates Foundation and Orient Life. Lyndra...
...Lyndra is testing capsule formulations of generic drugs and proprietary compounds from partner companies. Lyndra...
...an undisclosed schizophrenia compound in 2019 and progress to a Phase II trial in 2020. Hongjiang Li Lyndra...
BioCentury | Jan 23, 2018
Distillery Techniques

Drug delivery

...200-500 ng/mL for cabotegravir for up to a week post-dose. Next steps in collaboration with Lyndra Inc....
...form for delivery of multiple antiretroviral (ART) agents LICENSING STATUS: Patent application filed; licensed to Lyndra Inc....
BioCentury | Nov 2, 2017
Company News

Allergan, Lyndra in AD formulation deal

...Allergan plc (NYSE:AGN) and Lyndra Inc. (Watertown, Mass.) partnered to develop once-weekly, oral formulations of Allergan’s treatments...
...of Allergan’s treatments for Alzheimer’s disease. Allergan may also add another candidate in any indication. Lyndra...
...Dec. 7, 2016 ). Lyndra Inc., Watertown, Mass. Allergan plc (NYSE:AGN), Dublin, Ireland Business: Neurology Chris Lieu Allergan plc Lyndra Inc....
Items per page:
1 - 10 of 18
BioCentury | Oct 20, 2020
Management Tracks

J&J promotes Kumar; plus moves at Krystal, Design, Centogene, Lyndra, Mereo and Neoleukin

...was associate general counsel at the non-profit.Could an IPO soon be in the works for Lyndra...
...companies public. The addition of  Eldridge is the third senior management hire this year for Lyndra...
...at Kartos Therapeutics Inc. Wyzga will continue to serve on Mereo’s board. Danielle Golovin Krystal Biotech Inc. Design Therapeutics Centogene N.V. Lyndra...
BioCentury | Dec 6, 2019
Preclinical News

Dec. 5 Preclinical Quick Takes: Simpler synthesis of Merck’s HIV therapy; plus MRSA antibiotic, once-monthly oral contraceptive

...infected moth larvae. MIT’s once-monthly oral contraceptive A Massachusetts Institute of Technology team led by Lyndra...
...contraceptive was detected in serum up to 29 days after oral delivery of the capsule. Lyndra...
...infectious and neurological diseases, transplant rejection and contraception (see “Star Treatment” ). BioCentury Staff Massachusetts Institute of Technology Lyndra...
BioCentury | Oct 4, 2019
Company News

Management tracks: J&J hires Bayer’s Swanson; plus Torque, Dynavax, Pact, Deciphera, NextCure, Retrophin, Verve, Jnana and more

...CSO. Bellinger is an attending cardiologist at Brigham and Women's Hospital and was CSO at Lyndra...
BioCentury | Jul 9, 2019
Company News

July 9 Company Quick Takes: Celgene, Nimbus expand deal; plus Gilead-Lyndra, Darzalex and more

...Gilead, Lyndra to develop long-acting HIV therapies Gilead Sciences Inc. (NASDAQ:GILD) gained exclusive rights from Lyndra...
...Financial terms are undisclosed. Gilead participated in Lyndra's $60.9 million series B in January (see "Lyndra...
...Eaton, Staff Writer Darzalex, daratumumab (JNJ-54767414, humax-cd38) SP-1373, VPD-107 tislelizumab (BGB-A317) Alector Inc. Altimmune Inc. BeiGene Ltd. Celgene Corp. Gilead Sciences Inc. Johnson & Johnson Lyndra...
BioCentury | Jun 3, 2019
Company News

Management tracks: Zai, Jazz, PTC, BIO and more

...biopharma division of the GE Healthcare unit of General Electric Co. (NYSE:GE). Drug delivery company Lyndra...
...preclinical sciences at Vertex Pharmaceuticals Inc. (NASDAQ:VRTX). Mark Zipkin, Staff Writer Biotechnology Industry Organization Jazz Pharmaceuticals plc Leo Pharma A/S Lyndra...
BioCentury | Mar 13, 2019
Preclinical News

Langer study describes once-monthly dosing system for tuberculosis

...The scientific team behind drug delivery company Lyndra Therapeutics described a delivery device capable of releasing...
...treatment regimens last 6-9 months, according to the CDC. Langer and Traverso are co-founders of Lyndra...
...is developing oral drug delivery systems for ultra-long drug release. All of the candidates in Lyndra's...
BioCentury | Feb 1, 2019
Financial News

Drug delivery company Lyndra raises $55M series B

...Investments, Gilead Sciences Inc. (NASDAQ:GILD), Invus, the Bill & Melinda Gates Foundation and Orient Life. Lyndra...
...Lyndra is testing capsule formulations of generic drugs and proprietary compounds from partner companies. Lyndra...
...2019 and progress to a Phase II trial in 2020. Lyndra Therapeutics Inc., Watertown, Mass. Hongjiang Li Lyndra...
BioCentury | Jan 29, 2019
Financial News

Drug delivery company Lyndra raises $55M series B

...Investments, Gilead Sciences Inc. (NASDAQ:GILD), Invus, the Bill & Melinda Gates Foundation and Orient Life. Lyndra...
...Lyndra is testing capsule formulations of generic drugs and proprietary compounds from partner companies. Lyndra...
...an undisclosed schizophrenia compound in 2019 and progress to a Phase II trial in 2020. Hongjiang Li Lyndra...
BioCentury | Jan 23, 2018
Distillery Techniques

Drug delivery

...200-500 ng/mL for cabotegravir for up to a week post-dose. Next steps in collaboration with Lyndra Inc....
...form for delivery of multiple antiretroviral (ART) agents LICENSING STATUS: Patent application filed; licensed to Lyndra Inc....
BioCentury | Nov 2, 2017
Company News

Allergan, Lyndra in AD formulation deal

...Allergan plc (NYSE:AGN) and Lyndra Inc. (Watertown, Mass.) partnered to develop once-weekly, oral formulations of Allergan’s treatments...
...of Allergan’s treatments for Alzheimer’s disease. Allergan may also add another candidate in any indication. Lyndra...
...Dec. 7, 2016 ). Lyndra Inc., Watertown, Mass. Allergan plc (NYSE:AGN), Dublin, Ireland Business: Neurology Chris Lieu Allergan plc Lyndra Inc....
Items per page:
1 - 10 of 18